• Net sales
  • Results
  • Cashflow
  • Investments/​R&D
Net sales
Results
Cashflow
Investments/​R&D

Net sales
first half-year 2021
(in CHF)
1,833 million +24.9% versus prior year

Net sales
first half-year 2021

+22.6% currency-adjusted growth

Chart is loading ...
Chart is loading ...
1 Adjusted for costs in connection with the Sanitec acquisition and integration

2 Restatement

Operating cashflow margin
first half-year 2021
(EBITDA margin) 34.2% +270 basis points versus prior year

Free cashflow
first half-year 2021(in CHF) 328 million +88.4% versus prior year

Investments in property, plant and equipment and intangible assets first half-year 2021 (in CHF) 54 million -1.1% versus prior year

R&D expenditures
first half-year 2021
(in CHF)
39 million 1.0 million above prior year